These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27237441)

  • 21. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors.
    Kjaer A; Knigge U
    Scand J Gastroenterol; 2015 Jun; 50(6):740-7. PubMed ID: 25959100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The radionuclide molecular imaging and therapy of neuroendocrine tumors.
    Li S; Beheshti M
    Curr Cancer Drug Targets; 2005 Mar; 5(2):139-48. PubMed ID: 15810878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
    Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
    J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
    Sanli Y; Yilmaz E; Subramaniam RM
    PET Clin; 2017 Oct; 12(4):423-435. PubMed ID: 28867113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Established nuclear medicine techniques for tumour diagnosis (tumour SPECT): can they still compete with (18)F-FDG-PET?].
    Schmidt M; Eschner W; Dietlein M; Theissen P; Schicha H
    Nuklearmedizin; 2005 Feb; 44(1):37-48; quiz N2-3. PubMed ID: 15711728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Role of
    Hemrom A; Arora G; Damle NA; Bal C
    Nucl Med Mol Imaging; 2022 Oct; 56(5):236-244. PubMed ID: 36310834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
    Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
    J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
    Boubaker A; Bischof Delaloye A
    Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
    Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
    J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of (18)F-FDG PET/CT, (123)I-MIBG SPECT, and CT in Restaging Patients Affected by Malignant Pheochromocytoma.
    Cantalamessa A; Caobelli F; Paghera B; Caobelli A; Vavassori F
    Nucl Med Mol Imaging; 2011 Jun; 45(2):125-31. PubMed ID: 24899991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
    Uslu L; Donig J; Link M; Rosenberg J; Quon A; Daldrup-Link HE
    J Nucl Med; 2015 Feb; 56(2):274-86. PubMed ID: 25572088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with (18)F-fluorodeoxyglucose positron emission tomography and (123)I-metaiodobenzylguanine scintigraphy in pediatric neuroblastoma: complementary roles in follow-up of patients.
    Gil TY; Lee DK; Lee JM; Yoo ES; Ryu KH
    Korean J Pediatr; 2014 Jun; 57(6):278-86. PubMed ID: 25076973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
    J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compared to
    Kroiss AS; Uprimny C; Shulkin BL; Frech A; Tilg H; Gasser RW; Sprinzl GM; Gruber L; Thomé C; Plangger C; Url C; Fraedrich G; Virgolini IJ
    Ann Nucl Med; 2017 Jun; 31(5):357-365. PubMed ID: 28349331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
    Xia J; Zhang H; Hu Q; Liu SY; Zhang LQ; Zhang A; Zhang XL; Wang YQ; Liu AG
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):649-660. PubMed ID: 29058276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Sharp SE; Shulkin BL; Gelfand MJ; Salisbury S; Furman WL
    J Nucl Med; 2009 Aug; 50(8):1237-43. PubMed ID: 19617326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.